Evidence map›Paper›PMID 37175168›Full record

ReviewMolecules (Basel, Switzerland)2023

β-Barrel Assembly Machinery (BAM) Complex as Novel Antibacterial Drug Target.

Qian Xu, Min Guo, Feiyuan Yu

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Antibiotic resistance inFrontiers in microbiology · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Vaccines · 2024
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Qian XuLaboratory of Molecular Pathology, Department of Pathology, Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou 515041, China.ORCID 0000-0002-1749-2406
Min GuoAllergy Clinic, Zibo Central Hospital, Zibo 255000, China.
Feiyuan YuDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou 515041, China.
Shantou University · CNCentral Hospital of Zibo · CN

Funding

Guangdong Basic and Applied Basic Research Foundation 2019A1515011193Guangdong Basic and Applied Basic Research Foundation 2021A1515010751Li Kashing Foundation NoneNational Natural Science Foundation of China 31900468Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province STKJ2021206
6 · The paper itself

Abstract

The outer membrane of Gram-negative bacteria is closely related to the pathogenicity and drug resistance of bacteria. Outer membrane proteins (OMPs) are a class of proteins with important biological functions on the outer membrane. The β-barrel assembly machinery (BAM) complex plays a key role in OMP biogenesis, which ensures that the OMP is inserted into the outer membrane in a correct folding manner and performs nutrient uptake, antibiotic resistance, cell adhesion, cell signaling, and maintenance of membrane stability and other functions. The BAM complex is highly conserved among Gram-negative bacteria. The abnormality of the BAM complex will lead to the obstruction of OMP folding, affect the function of the outer membrane, and eventually lead to bacterial death. In view of the important role of the BAM complex in OMP biogenesis, the BAM complex has become an attractive target for the development of new antibacterial drugs against Gram-negative bacteria. Here, we summarize the structure and function of the BAM complex and review the latest research progress of antibacterial drugs targeting BAM in order to provide a new perspective for the development of antibiotics.

Indexed as

Escherichia coli ProteinsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBiological TransportEscherichia coliGram-Negative BacteriaProtein FoldingAnti-Bacterial AgentsBacterial Outer Membrane ProteinsEscherichia coli ProteinsBamABAM complexdrug resistancedrug targetGram-negative bacteriaβ-barrel assembly machinery

Identifiers

PMID37175168
PMCPMC10180388
OpenAlexW4367317678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.